IMMUNOGLOBULIN HUMAN NORMAL (HYQVIA) HOMECARE 10%

  • BELFAST HEALTH AND SOCIAL CARE TRUST

F14: Notice for changes or additional information

Notice identifier: 2024/S 000-007616

Procurement identifier (OCID): ocds-h6vhtk-043a1f

Published 11 March 2024, 9:18am



Section one: Contracting authority/entity

one.1) Name and addresses

BELFAST HEALTH AND SOCIAL CARE TRUST

LISBURN ROAD

BELFAST

BT97AB

Contact

Norma Moore

Email

norma.moore@belfasttrust.hscni.net

Country

United Kingdom

Region code

UKN06 - Belfast

Justification for not providing organisation identifier

Not on any register

Internet address(es)

Main address

https://belfasttrust.hscni.net


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

IMMUNOGLOBULIN HUMAN NORMAL (HYQVIA) HOMECARE 10%

Reference number

DACPM2023-95

two.1.2) Main CPV code

  • 33000000 - Medical equipments, pharmaceuticals and personal care products

two.1.3) Type of contract

Supplies

two.1.4) Short description

Procurement of IMMUNOGLOBULIN HUMAN NORMAL (HYQVIA) HOMECARE 10%


Section six. Complementary information

six.6) Original notice reference

Notice number: 2024/S 000-004959


Section seven. Changes

seven.1.2) Text to be corrected in the original notice

Section number

IV.1.1

Place of text to be modified

Type of procedure

Instead of
Text

Award of a contract without prior publication of a call for competition in the cases listed below

The services can be provided only by a particular economic operator for the following reason:

protection of exclusive rights, including intellectual property rights

Explanation:

These are branded patent protected medicines that are essential to patient care and are available from only one economic operator. The absence of competition is not a result of the artificial narrowing of the parameters of the procurement.

Read
Text

Award of a contract without prior publication of a call for competition in the cases listed below

Additional deliveries by the original supplier

Explanation:

These essential medicines are required from this supplier to ensure continuity of patient care, specifically for homecare support. The absence of competition is not the artificial narrowing of the parameters of the procurement.